Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The abnormal electrical signals in pulmonary veins refer to pathological electrical impulses that commonly originate in the myocardial sleeves extending from the left atrium into the pulmonary veins. These ectopic signals are a well-established trigger for paroxysmal atrial fibrillation. The underlying mechanisms include enhanced automaticity, triggered activity, and reentry phenomena, facilitated by the unique electrophysiological properties and complex fiber architecture of the pulmonary vein myocardium. Treatment strategies targeting these signals—most notably pulmonary vein isolation (PVI) by catheter ablation—are a cornerstone of contemporary AF management. The phenomenon is not a discrete molecular target but represents a pathophysiological process involving a complex interplay of ion channels and cardiac conduction tissue[1][2][3][4][5][6].
Drug-based rhythm control (suppresses abnormal automaticity, conduction, or reentry) Pulmonary vein isolation ablation (physically disrupts the ability of abnormal electrical signals to reach the left atrium)[5][6][7]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Abnormal electrical signals in pulmonary veins.